Voyager Therapeutics plans to begin a clinical trial in the second half of the year of its investigational gene therapy for Alzheimer's disease after positive toxicology data. The biotechnology ...

A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...

Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July 13, 2026 (GLOBE NEWSWIRE) -- Voyager ...

On the second floor of Pennington’s Clinical Research Building, cutting-edge research is exploring GLP-1 drugs, exercise and ...

During an on-site inspection, investigators found that the semaglutide was manufactured in an unnamed lab not registered with the FDA.

GLP-1 receptor agonists promote weight loss via gut-hormone mimetics that curb appetite, slow gastric emptying, and improve ...

A new study tracking people on GLP-1 weight loss jabs has picked up on changes happening inside the body that go far beyond the number on the scales, some of which are catching experts off guard.

GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...

A JAMA study sent one patient to 49 online GLP-1 sellers. Here's what it took to get prescribed, and what that says about ...

The state Medical Board accused a doctor and pharmacist of improperly manufacturing weight loss drugs out of a Sorrento Valley pain clinic.

GMR Peptides introduces a range of high-purity research peptides supported by structured verification standards and transparent sourcing ...

Several meal subscription services now have special menus for GLP-1 users. Here are the best options to help you hit your ...